Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.
<h4>Background</h4>Data on the use of oral anticoagulation (OAC) and antiplatelet therapy and the risk of bleeding and stroke amongst Asian patients with atrial fibrillation (AF) are limited. We investigated the risks of bleeding and stroke with use of oral anticoagulation (OAC) and anti...
Main Authors: | Pei-Chun Chen, Gregory Y H Lip, Grace Yeh, Hung-Ju Lin, Kuo-Liong Chien |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0125257 |
Similar Items
-
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
by: Romain Chopard, et al.
Published: (2018-04-01) -
Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
by: Kang-Ho Choi, et al.
Published: (2021-05-01) -
Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
by: Anne Gulbech Ording, et al.
Published: (2021-07-01) -
Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
by: Wern Yew Ding, et al.
Published: (2020-02-01) -
Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01)